Users online: 1973    [ij] [ij] [ij] 
Email id

Year : 2020, Volume : 13, Issue : 12
First page : ( 6243) Last page : ( 6247)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.01088.4

Synthesis, spectral characterization and anticancer activity of novel pyrimidine derivatives

Banu S. Shakila1*, Krishnamoorthy G.1, Senthamarai R.1, Jaabir M S Mohamed2

11Department of Pharmaceutical Chemistry, Periyar College of Pharmaceutical Sciences, Tiruchirappalli, Tamil NaduIndia.

2Department of Biotechnology, National College, Tiruchirappalli, Tamil NaduIndia.

*Corresponding Author E-mail: sbpharma84@gmail.com

Online published on 15 February, 2021.


The main objective of this work was to synthesize, characterize and evaluate the anticancer activity of novel pyrimidine derivatives. The present investigation was undertaken to synthesize pyrimidine derivatives containing pyrrole nucleus The compounds 4-[aminomethyl]-N-(4-methyl-3-{[4-(1H-pyrrol-2-yl) pyrimidin-2-yl]amino}phenyl) benzamide (13f) and 4-[(propylamino) methyl]-N-(4-methyl-3-{ [4-(1H- pyrrol-2-yl) pyrimidin-2 -yl] amino} phenyl) benzamide (13h) was prepared by conventional method. All the synthesized compounds were characterized by spectral (IR, NMR and MS) methods. The synthesized compounds were evaluated for their in vitro anticancer activity against non-small cell lung cancer A549 cell line by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. All the synthesized compounds showed characteristic peaks in FTIR, 1H NMR and Mass spectral analysis. In vitro anticancer activity revealed that 13f and 13h showed more potent anticancer activity as compared to the standard drug sunitinib. We designed and synthesized novel pyrimidine derivatives by conventional method. The anticancer activity determined by MTT assay showed compound 13f and 13h can be developed as a potential anticancer agent.



Pyrimidine, Pyrrole, Sunitinib, Spectral studies, MTT assay.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
610,857,600 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.